AMGN: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/aebbaff0-bb13-4ed6-bae5-bb6ac24576c2/","filing_uuid":"aebbaff0-bb13-4ed6-bae5-bb6ac24576c2","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/aebbaff0-bb13-4ed6-bae5-bb6ac24576c2/print/","filing_document_content_type":"text/html","income":"37500.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Doug Schwartz","dt_posted":"2026-07-10T12:10:14-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"322 5th Street SE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":401105493,"url":"https://lda.gov/api/v1/registrants/401105493/","house_registrant_id":null,"name":"HILLNORTH LLC","description":"Public Affairs Consultant","address_1":"322 5th Street SE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DOUG SCHWARTZ","contact_telephone":"+1 202-276-0323","dt_updated":"2026-07-16T12:09:08.342746-04:00"},"client":{"id":58627,"url":"https://lda.gov/api/v1/clients/58627/","client_id":58627,"name":"AMGEN INC.","general_description":"Biotechnology","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the pharmaceutical industry.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72074,"prefix":null,"prefix_display":null,"first_name":"DOUG","nickname":null,"middle_name":null,"last_name":"SCHWARTZ","suffix":null,"suffix_display":null},"covered_position":"COS, Office of Asst Secretary of Energy, Department of Energy, 2003-04 Associate Director, Office of Cabinet Affairs, The White House, 2004-05 Chief of Staff, Office of Under Secretary of Energy, Department of Energy, 2005-09","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}